Timothy Eley

4.5k citations
63 papers · 3.8k · 3 hit papers · h-index 25

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 43
    • HIV/AIDS drug development and treatment 18
    • Viral gastroenteritis research and epidemiology 3

Timothy Eley

63 papers receiving 3.7k citations

Timothy Eley's Hit Papers

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection 2014 · 971 citations
9710+4+9Years since publication250500750

Peers

Timothy Eley
Comparison fields: 5 of 86
  • Hepatology 3.1k
  • Epidemiology 1.8k
  • Infectious Diseases 875
  • Rheumatology 213
  • Pharmacology 114
Replace Mitchell N. Davis with:
Mitchell N. Davis United States
Fiona McPhee United States
Fernando Lopes Gonçales Brazil
Andrew J. Muir United States
E. Jenny Heathcote Canada
Federico Mensa United States
Hadas Dvory‐Sobol United States
Robert Reindollar United States
Nathalie Boyer France
Thomas J. Podsadecki United States
Timothy Eley relative to Mitchell N. Davis United States Mitchell N. Davis's profile →
Citations per field
00.5×2×2.9×
Mitchell N. Davis · 1×
Citations per year

Countries citing papers authored by Timothy Eley

Since Specialization
Citations

This map shows the geographic impact of Timothy Eley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Eley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Eley more than expected).

Fields of papers citing papers by Timothy Eley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Eley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Eley. The network helps show where Timothy Eley may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy Eley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy Eley Line = papers co-authored together Timothy Eley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Hit paper breakdown →
2014971
2
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
Hit paper breakdown →
2012517
3
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection
Hit paper breakdown →
2014473
4 2012211
5 2013176
6 2013131
7 2013108
8 200989
9 201272
10 201560
11 201155
12 201053
13 201153
14 201848
15 201547
16 201247
17 201345
18 201344
19 201442
20 201037

About Timothy Eley

Timothy Eley is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Genetics and Pharmacology, having authored 63 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (43 papers), HIV/AIDS drug development and treatment (18 papers), Hepatitis B Virus Studies (17 papers), Liver Disease Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (5 papers), Viral gastroenteritis research and epidemiology (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Hepatology (3.1k citations), Epidemiology (1.8k citations), Infectious Diseases (875 citations), Rheumatology (213 citations) and Pharmacology (114 citations). Timothy Eley has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Fiona McPhee, Richard Bertz, David Gardiner, Dennis M. Grasela, Claudio Pasquinelli, Megan Wind‐Rotolo, Anna Persson, Anna S. Lok, Eric Lawitz and Gregory T. Everson. Their work appears in journals such as Journal of Hepatology, Antiviral Therapy, Journal of Pharmaceutical and Biomedical Analysis, Clinical Pharmacokinetics and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact